DNA Testing/Diagnostics is the determination of bloodlinesand the genetic diagnosis of vulnerabilities to inherited diseases.
Scope of the Report:
This report studies the DNA Testing/Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the DNA Testing/Diagnostics market by product type and applications/end industries.
With the rising incidences of genetic, infectious, and chronic diseases, reduction in prices of genetic sequencing, DNA Testing/Diagnostics growing adoption of precision medicine diagnostic techniques.
The global DNA Testing/Diagnostics market is valued at 11200 million USD in 2017 and is expected to reach 21200 million USD by the end of 2023, growing at a CAGR of 11.2% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of DNA Testing/Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
454 Life Sciences
Thermo Fisher Scientific
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
NGS DNA Diagnosis
Market Segment by Applications, can be divided into
Pharmacogenomics Diagnostic Testing